Company news

Hikma Pharmaceuticals PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Circ re. Roxane Acquisition

February 11, 2016

Hikma Analyst and Investor Call

February 10, 2016

Circ re. Roxane Acquisition and EGM

January 22, 2016

Shareholders' Agreement and Board Appointment

December 24, 2015

Hikma announces sale of Ben Venue manufacturing

November 25, 2015

Resolution to FDA Warning Letter

November 18, 2015

Block Listing of Share

October 22, 2015

Audit Tender

September 18, 2015

Hikma agrees to acquire EIMC United Pharmaceutical

September 8, 2015

Interim Results

August 19, 2015

Hikma Founder Samih Darwazah passes away

May 18, 2015

AGM Trading Update

May 14, 2015

Hikma launches caffeine citrate injection

May 12, 2015

Hikma prices debut $500 million five-year eurobond

April 1, 2015

Fixed income investor meetings

March 25, 2015

Hikma Delivers Insights at World Economic Forum

January 27, 2015

Notification of major interest in shares

January 21, 2015

Hikma to launch colchicine 0.6mg capsules

January 12, 2015

Interim Management Statement

November 6, 2014

Hikma announces receipt of Warning Letter from FDA

October 24, 2014

Statement re Colchicine

October 10, 2014

Regulatory Approval Colchicine

September 30, 2014

Dividend Declaration

August 20, 2014

Notice of Interim Results Announcement

August 7, 2014

Results of AGM

May 15, 2014

Successful resolution to US FDA warning letter

April 2, 2014

Notification of major interests in shares

February 27, 2014

Block Listing of Shares

February 21, 2014

Re Agreement

November 20, 2013

Hikma entering Ethiopian pharmaceutical market

September 18, 2013

Signing of Exclusive Agreement with Theravance

July 1, 2013

Hikma update on global Injectables business

April 17, 2013

Preliminary Results

March 13, 2013

Response to unsolicited enquiries

March 1, 2013

Hikma signs agreement with EffRx

February 4, 2013

Non Regulatory Announcement

January 3, 2013

Product Launch

December 13, 2012

Building Public Trust Awards - Highly Commended

November 27, 2012

Hikma & GP Pharm signs license & supply agreement

October 22, 2012

Injectables Analyst and Investor Day USA

October 11, 2012

Half Yearly Report

August 16, 2012

Annual Financial Report & AGM Notice

April 13, 2012

Tender Offer

January 17, 2012

Hikma in-licenses proprietary injectable product

August 17, 2011

Hikma enhances its API sourcing capabilities

July 11, 2011

Statement re Completion of Acquisition

May 3, 2011

Re Agreement with Unimark Remedies Limited

April 15, 2011

Appointments

January 24, 2011

Product Update

October 18, 2010

Block Listing for Share Schem

October 15, 2010

← Newer news releases · Older news releases →

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 50 decks. Every deck is listed under its year.